- Home
- TARS vs DX Comparison
TARS vs DX Comparison
Compare TARS & DX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | DX |
|---|---|---|
| Founded | 2016 | 1987 |
| Country | United States | United States |
| Employees | N/A | 22 |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARS | DX |
|---|---|---|
| Price | $75.30 | $13.99 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $80.56 | $14.25 |
| AVG Volume (30 Days) | 616.6K | ★ 5.5M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 14.54% |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $51.34 | N/A |
| Revenue Next Year | $29.34 | N/A |
| P/E Ratio | ★ N/A | $5.66 |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $38.51 | $10.79 |
| 52 Week High | $85.25 | $14.93 |
Technical Indicators
Market Signals| Indicator | TARS | DX |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 47.31 |
| Support Level | $65.62 | $13.63 |
| Resistance Level | $76.81 | $14.12 |
| Average True Range (ATR) | 3.86 | 0.23 |
| MACD | 1.80 | -0.01 |
| Stochastic Oscillator | 75.85 | 51.00 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About DX Dynex Capital Inc.
Dynex Capital Inc is an internally managed mortgage real estate investment trust, which invests in mortgage-backed securities. The company invests in residential and commercial mortgage-backed securities. Its objective is to provide attractive risk-adjusted returns to shareholders over the long term that are reflective of a leveraged, high quality fixed income portfolio with a focus on capital preservation. Its investments consist principally of Agency mortgage-backed securities including, residential MBS and commercial MBS.